From: Assessment of antibiotic prescribing in Latvian general practitioners
Age group | <5 | 5-14 | 15-64 | > = 65 | Total | DDD* |
---|---|---|---|---|---|---|
N(%) | N(%) | N(%) | N(%) | N(%) | DDD (%) | |
Penicillins with extendedspectrum (J01CA) | 113 (42,8) | 119 (44,6) | 329 (31,9) | 48 (24,4) | 609 (34,6) | 649,8 (35,3) |
Amoxicillin/clavulanate (J01CR) | 37 (14,0) | 42 (15,7) | 220 (21,3) | 30 (15,2) | 329 (18,7) | 416,6 (22,7) |
Macrolides (J01FA) | 38 (14,4) | 31 (11,6) | 154 (14,9) | 24 (12,2) | 247 (14,0) | 270,7 (14,7) |
Trimetroprim/sulfametoxazole (J01EE) | 49 (18,6) | 20 (7,5) | 36 (3,5) | 4 (2,0) | 109 (6,2) | 35 (1,9) |
First generation cephalosporins (J01DB) | 17 (6,4) | 24 (9,0) | 55 (5,3) | 11 (5,6) | 107 (6,1) | 38,3 (2,1) |
Quinolones (J01MA) | 0 | 3 (1,1) | 81 (7,8) | 33 (15,7) | 117 (6,5) | 185,1 (10,1) |
Tetracyclines (J01AA) | 0 | 5 (1,9) | 57 (5,5) | 20 (10,2) | 82 (4,7) | 152,5 (8,3) |
Other | 10 (3,8) | 23 (8,6) | 100 (9,7) | 27 (13,7) | 160 (9,1) | 91,3 (5,0) |
Total | 264 (100) | 267 (100) | 1032 (100) | 197 (100) | 1760 (100) | 1839,3 (100) |